Status:
COMPLETED
Adherence in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04281)(COMPLETED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Hepatitis C, Chronic
Hepacivirus
Eligibility:
All Genders
18+ years
Brief Summary
Patients receiving a patient assistance program during therapy for Hepatitis C will be enrolled into this study. All patients will receive PegIntron pen and Rebetol according to label and the patient ...
Eligibility Criteria
Inclusion
- Adult patients with hepatitis C
Exclusion
- According to the products' labeling (refer to Warnings, contraindications, and safety sections).
Key Trial Info
Start Date :
March 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
601 Patients enrolled
Trial Details
Trial ID
NCT00704522
Start Date
March 1 2005
End Date
April 1 2009
Last Update
October 6 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.